Seres Therapeutics Stock Price on November 20, 2024
| MCRB Stock | USD 0.96 0.01 1.03% |
Below is the normalized historical share price chart for Seres Therapeutics extending back to June 26, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Seres Therapeutics stands at 0.96, as last reported on the 25th of December, with the highest price reaching 0.99 and the lowest price hitting 0.95 during the day.
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. Seres Therapeutics appears to be very risky, given 3 months investment horizon. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.067, which indicates the firm had a 0.067% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Seres Therapeutics, which you can use to evaluate the volatility of the company. Please review Seres Therapeutics' Variance of 41.32, coefficient of variation of (7,454), and insignificant Risk Adjusted Performance to confirm if our risk estimates are consistent with your expectations.
At present, Seres Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 141.8 K, whereas Total Stockholder Equity is projected to grow to (42.6 M). . As of December 25, 2024, Price To Sales Ratio is expected to decline to 1.35. In addition to that, Price Earnings Ratio is expected to decline to -1.65. Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2015 | 200 Day MA 0.8802 | 50 Day MA 0.7989 | Beta 2.05 |
Seres |
Sharpe Ratio = 0.067
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MCRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.05 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Seres Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding it to a well-diversified portfolio.
Price Book 6.8891 | Enterprise Value Ebitda (2.07) | Price Sales 1.3044 | Shares Float 98.6 M | Wall Street Target Price 3.874 |
Related Headline
Syros Pharmaceuticals Headline on 20th of November 2024
Syros pharmaceuticals chief development officer sells shares... by investing.com
Syros pharmaceuticals chief development officer sells shares for 7,949
Seres Therapeutics Valuation on November 20, 2024
It is possible to determine the worth of Seres Therapeutics on a given historical date. On November 20, 2024 Seres was worth 0.68 at the beginning of the trading date compared to the closed value of 0.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Seres Therapeutics stock. Still, in general, we apply an absolute valuation method to find Seres Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Seres Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Seres Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.58 | 0.70 | 0.58 | 0.69 | 4,400,637 | |
11/20/2024 | 0.68 | 0.88 | 0.67 | 0.81 | 12,200,605 |
| 0.83 | 0.88 | 0.72 | 0.73 | 4,167,572 |
| Backtest Seres Therapeutics | | | Seres Therapeutics History | | | Seres Therapeutics Valuation | Previous | Next |
Seres Therapeutics Trading Date Momentum on November 20, 2024
| On November 21 2024 Seres Therapeutics was traded for 0.73 at the closing time. The top price for the day was 0.88 and the lowest listed price was 0.72 . The trading volume for the day was 4.2 M. The trading history from November 21, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 9.88% . The trading price change against the current closing price is 24.69% . |
Seres Therapeutics Fundamentals Correlations and Trends
By evaluating Seres Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Seres Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Seres financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Seres Therapeutics Stock history
Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 128 M | 134.4 M | |
| Net Loss | -225.1 M | -213.9 M |
Seres Therapeutics Quarterly Net Working Capital |
|
Seres Therapeutics Stock Technical Analysis
Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Seres Therapeutics Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Seres Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Seres Therapeutics December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Seres Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Seres Therapeutics shares will generate the highest return on investment. By undertsting and applying Seres Therapeutics stock market strength indicators, traders can identify Seres Therapeutics entry and exit signals to maximize returns
Seres Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |